期刊文献+

肝炎患者血清PCⅢ的检测在临床上的应用

Clinical applicatinn of serum PCⅢ detection among hepatitis sufferers
下载PDF
导出
摘要 目的研究血清Ⅲ型前胶原(PCⅢ)对肝纤维化的诊断价值。方法采用放免法测定100例各种肝炎患者及120例健康者血清PCⅢ水平,比较各组病毒性肝炎之间及健康献血者血清PCⅢ差异。结果血清PCⅢ水平在慢性肝炎(中度)患者明显升高,以慢性肝炎(重度)、肝硬化者为最高,3组患者与其他组比较,差异有统计学意义(P<0.05),其升高程度与肝纤维化及肝病严重程度呈正相关。结论动态测定血清PCⅢ水平,可作为反映慢性肝病肝纤维化严重程度和预后的指标,对于肝炎的诊断有着重要意义。 Objective To study the diagnostic value of serum PC IH for hepatic fibrosis.Methods Radioimmunoassay(RIA) was used to detect the level of PCIII in the serum of 100 patients with various hepatitis and 120 healthy people, and compared the different level of PC III in their serum.Results The PC m level in the serum of patients with medium chronic hepatitis obviously went up ,and those of severe chronic hepatitis and hepatic cirrhosis were the highest.Differences between these three groups and other groups were of statistical signifi- cance(P〈0.05).The increased degree of serum PC III was positively related to the degree of hepatic fibrosis and severity of liver diseases. Conclusion Dynamic measurement of PCIII level in serum can reflect the fibrosis degree of chronic liver disease and it is significant in the diagnosis of hepatitis.
出处 《中国疗养医学》 2014年第3期248-248,共1页 Chinese Journal of Convalescent Medicine
关键词 肝病 血清Ⅲ型前胶原 临床应用 Hepatopathy Type III Collagen(PC III ) Clinical application
  • 相关文献

参考文献5

二级参考文献32

  • 1叶远红,张安忠.慢性肝病患者血清Ⅳ型胶原、透明质酸含量及其临床意义[J].实用肝脏病杂志,2003,6(1):26-27. 被引量:30
  • 2高春芳,孔宪涛.肝纤维化生化诊断指标的选择和评价[J].现代医药卫生,2004,20(16):1571-1574. 被引量:11
  • 3李军,张纬,田茶,赵玉良,齐顺祥.血清细胞外基质检测对肝纤维化诊断价值的研究[J].河北医药,2007,29(1):51-52. 被引量:5
  • 4孔宪涛.肝纤维化的早期诊断[J].中华肝脏病杂志,2000,8(4):241-242.
  • 5Poynard T, Aubert A, Bedossa P, et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology, 1991, 100(5 Pt 1):1397-1402.
  • 6Hayasaka A, Saisho H. Serum markers as tools to monitor liver fibrosis. Digestion, 1998, 59(4):381-384.
  • 7Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology, 2005, 41 ( 1 ):26-31.
  • 8Tran A, Hastier P, Barjoan EM, et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Bio, 2000, 24(6/7):626-630.
  • 9Poynard T, Imbert-Bismut F, Ratziu V, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat, 2002, 9(2):128-133.
  • 10Tangkijvanich P, Kongtawelert P, Pothacharoen P, et al. Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease. Asian Pac J Allergy Immunol, 2003, 21(2):115-120.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部